New hope for those with Alzheimer's Disease
Recently, scientists announced that an anti-amyloid drug may protect the brain from the progression of Alzheimer's Disease. Amyloid is the protein that builds up in the brain which can lead to sticky plaques that compromises nerve cells. The studies showed the drug decreases the amount of amyloid in the brain after 18 months, potentially slowing the progression of Alzheimer's.
Dr. Tom Zodo will discuss on recently announced advancements in clinical research as well as look at how management of daily living, i.e., exercise and diet, can impact Alzheimer’s development and progression.
About our speaker
Tom Zoda, Ph.D., is Executive Vice President and General Manager, CNS, at Syneos Health, and has been with the organization since 2015.
Previously, Dr. Zoda was with INC Research. He completed his doctoral degree in microbiology, specializing in immunology, at the University of Texas Health Science Center at San Antonio, followed by postdoctoral work at Dartmouth Medical College.
Dr. Zoda has extensive experience overseeing research studies including design and direction of multiple Phase II and III studies including those focused in multiple sclerosis, epilepsy, Alzheimer’s disease, Parkinson’s disease, insomnia, chronic and acute pain, and various psychiatric disorders such as schizophrenia, anxiety, and bipolar disorder.
Dr. Zoda previously also worked for Tanox Biosystems, Inc., overseeing the development of therapeutic antibodies and vaccines for the treatment of allergy.
Agenda:
6:50am - Coffee & Networking
7:10am - Breakfast Buffet
7:25am - Introductions & Announcements
7:50am - Speaker Introduction
8:20am - Q&A
8:30am - Have a wonderful Wednesday!
Directions and Parking to UT Club
Breakfast Fees & Policy
